Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth A Ross

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 21, 2016
Development of indole sulfonamides as cannabinoid receptor negative allosteric modulatorsIain R Greig, Gemma L Baillie, Mostafa Abdelrahman, et al.
Frontiers in Integrative Neuroscience|June 12, 2014
The relationship between vestibular function and topographical memory in older adultsFred H Previc, Wesley W Krueger, Ruth A Ross, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 24, 2011
Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed miceSuthat Liangpunsakul, Yasmeen Rahmini, Ruth A Ross, et al.
European Journal of Pharmacology|March 23, 2004
6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonistAdèle Thomas, Ruth A Ross, Bijali Saha, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2008
Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylationSuthat Liangpunsakul, Sung-Eun Wou, Yan Zeng, et al.
Experimental Neurology|August 6, 2015
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseRoss B Mounsey, Sarah Mustafa, Lianne Robinson, et al.
British Journal of Pharmacology|June 4, 2024
Positive allosteric modulation of the cannabinoid CB<sub>1</sub> receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kineticsHayley M Green, Jamie J Manning, Ian R Greig, et al.
Neuro-Signals|December 17, 2010
Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neuronesLynne Shanley, Scott Davidson, Marissa Lear, et al.
Alcohol (Fayetteville, N.Y.)|December 3, 2014
Increasing serum pre-adipocyte factor-1 (Pref-1) correlates with decreased body fat, increased free fatty acids, and level of recent alcohol consumption in excessive alcohol drinkersSuthat Liangpunsakul, Rachel Bennett, Chi Westerhold, et al.
ACS Pharmacology & Translational Science|December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?Hayley M Green, David B Finlay, Ruth A Ross, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|August 21, 2016
Development of indole sulfonamides as cannabinoid receptor negative allosteric modulatorsIain R Greig, Gemma L Baillie, Mostafa Abdelrahman, et al.
Frontiers in Integrative Neuroscience|June 12, 2014
The relationship between vestibular function and topographical memory in older adultsFred H Previc, Wesley W Krueger, Ruth A Ross, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 24, 2011
Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed miceSuthat Liangpunsakul, Yasmeen Rahmini, Ruth A Ross, et al.
European Journal of Pharmacology|March 23, 2004
6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonistAdèle Thomas, Ruth A Ross, Bijali Saha, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2008
Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylationSuthat Liangpunsakul, Sung-Eun Wou, Yan Zeng, et al.
Experimental Neurology|August 6, 2015
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseRoss B Mounsey, Sarah Mustafa, Lianne Robinson, et al.
British Journal of Pharmacology|June 4, 2024
Positive allosteric modulation of the cannabinoid CB<sub>1</sub> receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kineticsHayley M Green, Jamie J Manning, Ian R Greig, et al.
Neuro-Signals|December 17, 2010
Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neuronesLynne Shanley, Scott Davidson, Marissa Lear, et al.
Alcohol (Fayetteville, N.Y.)|December 3, 2014
Increasing serum pre-adipocyte factor-1 (Pref-1) correlates with decreased body fat, increased free fatty acids, and level of recent alcohol consumption in excessive alcohol drinkersSuthat Liangpunsakul, Rachel Bennett, Chi Westerhold, et al.
ACS Pharmacology & Translational Science|December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1<i>H</i>-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?Hayley M Green, David B Finlay, Ruth A Ross, et al.
Pageof 7